Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lingli Dong

Showing results (51-60 of 198) with videos related to

Pageof 20
Sort By:
Clinical and Experimental Rheumatology|September 6, 2018
Tocilizumab and the risk of respiratory adverse events in patients with rheumatoid arthritis: a systematic review and meta-analysis of randomised controlled trialsZhe Geng, Yikai Yu, Shaoxian Hu, et al.
Clinical Rheumatology|May 3, 2025
Effects of telitacicept in SLE patients with antiphospholipid antibody positivity: a retrospective self-controlled case seriesLiling Zhou, Yong You, Shaozhe Cai, et al.
Plos One|January 4, 2013
A new class of wheat gliadin genes and proteinsOlin D Anderson, Lingli Dong, Naxin Huo, et al.
Annals of Nuclear Medicine|May 23, 2022
Clinical value of <sup>18</sup>F-FDG PET/CT in IgG4-related diseaseZhiqian Bai, Tianshu Zhou, Zhihua Yu, et al.
Frontiers in Immunology|August 15, 2022
Potential roles of non-lymphocytic cells in the pathogenesis of IgG4-related diseaseShaozhe Cai, Ziwei Hu, Yu Chen, et al.
Biomed Research International|August 15, 2015
Elevated Serum Levels of Soluble CD30 in Ankylosing Spondylitis Patients and Its Association with Disease Severity-Related ParametersRongfen Gao, Wei Sun, Yu Chen, et al.
Clinical Rheumatology|September 26, 2022
Clinical characteristics of SLE patients infected with Epstein-Barr virus and potential associated risk factorsBingxia Ming, Ma Bai, Shaozhe Cai, et al.
The Journal of Biological Chemistry|October 6, 2005
Enzymatically active ADAMTS13 variants are not inhibited by anti-ADAMTS13 autoantibodies: a novel therapeutic strategy?Wenhua Zhou, Lingli Dong, David Ginsburg, et al.
Pharmaceuticals (Basel, Switzerland)|December 31, 2025
Myricetin Attenuates IMQ-Induced Psoriatic Inflammation Through Multi-Target Modulation: Evidence from Network Pharmacology and Experimental ValidationDeqiao Qin, Rongfen Gao, Lijuan Wu, et al.
Seminars in Arthritis and Rheumatism|June 13, 2022
Efficacy of plasma exchange on top of standard immunosuppressive therapy in adult autoimmune inflammatory rheumatic diseases-associated macrophage activation syndrome, a single center real-world analysisYuxue Chen, Ziwei Hu, Shaozhe Cai, et al.
Pageof 20

Showing results (51-60 of 198) with videos related to

Sort By:
Pageof 20
Clinical and Experimental Rheumatology|September 6, 2018
Tocilizumab and the risk of respiratory adverse events in patients with rheumatoid arthritis: a systematic review and meta-analysis of randomised controlled trialsZhe Geng, Yikai Yu, Shaoxian Hu, et al.
Clinical Rheumatology|May 3, 2025
Effects of telitacicept in SLE patients with antiphospholipid antibody positivity: a retrospective self-controlled case seriesLiling Zhou, Yong You, Shaozhe Cai, et al.
Plos One|January 4, 2013
A new class of wheat gliadin genes and proteinsOlin D Anderson, Lingli Dong, Naxin Huo, et al.
Annals of Nuclear Medicine|May 23, 2022
Clinical value of <sup>18</sup>F-FDG PET/CT in IgG4-related diseaseZhiqian Bai, Tianshu Zhou, Zhihua Yu, et al.
Frontiers in Immunology|August 15, 2022
Potential roles of non-lymphocytic cells in the pathogenesis of IgG4-related diseaseShaozhe Cai, Ziwei Hu, Yu Chen, et al.
Biomed Research International|August 15, 2015
Elevated Serum Levels of Soluble CD30 in Ankylosing Spondylitis Patients and Its Association with Disease Severity-Related ParametersRongfen Gao, Wei Sun, Yu Chen, et al.
Clinical Rheumatology|September 26, 2022
Clinical characteristics of SLE patients infected with Epstein-Barr virus and potential associated risk factorsBingxia Ming, Ma Bai, Shaozhe Cai, et al.
The Journal of Biological Chemistry|October 6, 2005
Enzymatically active ADAMTS13 variants are not inhibited by anti-ADAMTS13 autoantibodies: a novel therapeutic strategy?Wenhua Zhou, Lingli Dong, David Ginsburg, et al.
Pharmaceuticals (Basel, Switzerland)|December 31, 2025
Myricetin Attenuates IMQ-Induced Psoriatic Inflammation Through Multi-Target Modulation: Evidence from Network Pharmacology and Experimental ValidationDeqiao Qin, Rongfen Gao, Lijuan Wu, et al.
Seminars in Arthritis and Rheumatism|June 13, 2022
Efficacy of plasma exchange on top of standard immunosuppressive therapy in adult autoimmune inflammatory rheumatic diseases-associated macrophage activation syndrome, a single center real-world analysisYuxue Chen, Ziwei Hu, Shaozhe Cai, et al.
Pageof 20